Pharmacological evidence for the activation of K+ channels by diclofenac

European Journal of Pharmacology

Volumn 438, Issue 1-2, 2002, Pages 85-91

  Ortiz, Mario I ^a,b   Torres López, Jorge E ^a,c   Castaeda Hernández, Gilberto ^a   Rosas, Rodolfo ^d   Vidal Cantú, Guadalupe C ^a   Granados Soto, Vinicio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^c UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^d Novartis Farmacéutica   (Mexico)

Author keywords

Apamin; Charybdotoxin; Diclofenac; Glibenclamide; Morphine; Pinacidil

Indexed keywords

4 AMINOPYRIDINE; DICLOFENAC; FORMALDEHYDE; GLIBENCLAMIDE; MORPHINE; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; TETRYLAMMONIUM; TOLBUTAMIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; FEMALE; HYPERPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE;

EID: 0036497248     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01288-8     Document Type: Article

References (41)

1. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test
2. + channels
3. Behavioral and electrophysiological evidence for an analgesic effect of a non-steroidal anti-inflammatory agent sodium diclofenac
4. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol: Experimental studies in the rat
5. Potassium channel pharmacology
6. + channels of muscle cells - Their properties, regulation, and functions
7. + channels
8. Characterization of an outward potassium current in canine jejunal circular smooth muscle and its activation by fenamates
9. Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channel
10. Involvement of potassium channels in amitriptyline and clomipramine analgesia
11. 2+-activated chloride and potassium currents in rabbit portal vein smooth muscle cells
12. + channels in the central nervous system
13. Inhibition of ATP-sensitive potassium channels of adult rat heart cells by anti-arrhythmic drugs
14. Ethical guidelines for investigations on experimental pain in conscious animals
15. + channels are involved in the mediation of intrathecal norepinephrine- or morphine-induced antinociception at the spinal level: A study using EMG planimetry of flexor reflex in rats
16. + channel pathway in the antinociceptive action of ketorolac
17. + channel inhibitors on relaxation induced by flufenamic and tolfenamic acids in guinea-pig trachea
18. Differences in the mechanism of antinociceptive action of non-steroidal anti-inflammatory drugs in the rat
19. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia
20. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents
21. Pharmacological properties of diclofenac sodium and its metabolites
22. + channels from mammalian skeletal muscle
23. Sildenafil produces antinociception and increases morphine antinociception in the formalin test
24. + channel blocker antagonizes morphine analgesia
25. + channel-acting drugs
26. In vivo inhibition of prostaglandin synthesis in rabbit kidney by non-steroidal anti-inflammatory drugs
27. Ca channels by niflumic, flufenamic, and mefenamic acids
28. The "glibenclamide-shift" of centrally acting antinociceptive agents in mice
29. + currents in the human neuroblastoma cell line SH-SY5Y
30. A family of calcium-dependent potassium channels from rat brain
31. + channels
32. + channels
33. Sulfonylureas blockade of neural and cardiac HERG channels
34. Diclofenac and pirprofen modify pituitary hypothalamic beta-endorphin concentrations
35. Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves
36. Diclofenac sodium: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
37. Mechanism of diclofenac analgesia: Direct blockade of inflammatory sensitization
38. Naloxone inhibits the early phase of diclofenac analgesia in man
39. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists, a common mechanism of action?
40. Standardization of the rat paw formalin test for evaluation of analgesics
41. Opioid δ receptor subtypes are associated with different potassium channels